ImmuCell
ICCC · NASDAQ
$10.45−$0.06 (−0.57%)TodayMarket closed ·
Prev close $10.51
Who owns ICCC
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 43.3% of ICCC’s shares.
- Knudsen (Ejnar A III)9.2%
- Pessin (Norman H)7.1%
- Rothschild (Jonathan E)5.7%
- SRK Capital, LLC5.5%
- Next 6 largest institutions15.8%
- All other shareholders56.7%
| Holder | Shares | % of shares |
|---|---|---|
| Knudsen (Ejnar A III) | 832.79K | 9.20% |
| Pessin (Norman H) | 644.02K | 7.12% |
| Rothschild (Jonathan E) | 514.00K | 5.68% |
| SRK Capital, LLC | 502.26K | 5.55% |
| Pessin (Sandra F) | 401.82K | 4.44% |
| Vanguard Capital Management, LLC | 268.13K | 2.96% |
| Morgan Stanley Smith Barney LLC | 233.91K | 2.58% |
| Brigham (Michael F) | 216.70K | 2.39% |
| Renaissance Technologies LLC | 171.09K | 1.89% |
| Pessin (Brian L) | 136.88K | 1.51% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 181.08K | 2.00% |
| Vanguard Extended Market Index Fund | 78.99K | 0.87% |
| Fidelity Extended Market Index Fund | 33.51K | 0.37% |
| iShares Micro-Cap ETF | 21.38K | 0.24% |
| DFA U.S. Core Equity 2 Portfolio | 18.38K | 0.20% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $75.96K (1 trade) of ICCC on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| te Boekhorst Paul Francis Olivier | Buy | 8.00K | $75.96K |
Short interest
Settled Sep 30, 2026
- Shares short
- 22.11K
- Days to cover
- 1.76
- % of shares outstanding
- 0.24%
- Average daily volume
- 12.54K
- Change since last report
- +11.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.